IVD Medical Holding Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for IVD Medical Holding.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 19.1% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Dec 12
IVD Medical Holding Limited's (HKG:1931) Shares Climb 29% But Its Business Is Yet to Catch Up
Oct 14Additional Considerations Required While Assessing IVD Medical Holding's (HKG:1931) Strong Earnings
Sep 27IVD Medical Holding Limited's (HKG:1931) 30% Dip In Price Shows Sentiment Is Matching Earnings
Aug 17Little Excitement Around IVD Medical Holding Limited's (HKG:1931) Earnings As Shares Take 38% Pounding
Jun 07These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Safely
May 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 25IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 03IVD Medical Holding Limited's (HKG:1931) 28% Price Boost Is Out Of Tune With Earnings
Mar 30IVD Medical Holding (HKG:1931) Is Paying Out A Larger Dividend Than Last Year
Mar 20If EPS Growth Is Important To You, IVD Medical Holding (HKG:1931) Presents An Opportunity
Mar 06IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Feb 08Calculating The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Oct 22IVD Medical Holding's (HKG:1931) Returns On Capital Are Heading Higher
Oct 01IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To CN¥0.0297
Aug 22IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05IVD Medical Holding (HKG:1931) Is Increasing Its Dividend To CN¥0.0556
Mar 22Returns At IVD Medical Holding (HKG:1931) Are On The Way Up
Feb 16Does IVD Medical Holding (HKG:1931) Have A Healthy Balance Sheet?
Oct 16Calculating The Intrinsic Value Of IVD Medical Holding Limited (HKG:1931)
Sep 28IVD Medical Holding (HKG:1931) Has A Rock Solid Balance Sheet
May 16IVD Medical Holding's (HKG:1931) Dividend Will Be Increased To HK$0.053
Apr 14IVD Medical Holding's (HKG:1931) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 23IVD Medical Holding (HKG:1931) Is Doing The Right Things To Multiply Its Share Price
Mar 16IVD Medical Holding (HKG:1931) Is Experiencing Growth In Returns On Capital
Jul 30These 4 Measures Indicate That IVD Medical Holding (HKG:1931) Is Using Debt Reasonably Well
May 04There's Been No Shortage Of Growth Recently For IVD Medical Holding's (HKG:1931) Returns On Capital
Apr 20IVD Medical Holding's (HKG:1931) Stock Price Has Reduced 44% In The Past Year
Mar 05Are IVD Medical Holding's (HKG:1931) Statutory Earnings A Good Guide To Its Underlying Profitability?
Feb 15
Here's What IVD Medical Holding Limited's (HKG:1931) Shareholder Ownership Structure Looks Like
Jan 31A Look At The Fair Value Of IVD Medical Holding Limited (HKG:1931)
Jan 16Does IVD Medical Holding (HKG:1931) Have The Makings Of A Multi-Bagger?
Jan 01How Does IVD Medical Holding Limited (HKG:1931) Fare As A Dividend Stock?
Dec 17Have Insiders Been Buying IVD Medical Holding Limited (HKG:1931) Shares This Year?
Dec 02IVD Medical Holding's(HKG:1931) Share Price Is Down 28% Over The Past Year.
Nov 19In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as IVD Medical Holding has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 3,065 | 260 | 127 | 165 | N/A |
| 3/31/2024 | 3,076 | 249 | 190 | 229 | N/A |
| 12/31/2023 | 3,088 | 238 | 252 | 292 | N/A |
| 9/30/2023 | 3,019 | 235 | 345 | 387 | N/A |
| 6/30/2023 | 2,950 | 232 | 438 | 481 | N/A |
| 3/31/2023 | 2,849 | 221 | 327 | 366 | N/A |
| 12/31/2022 | 2,749 | 210 | 215 | 250 | N/A |
| 9/30/2022 | 2,735 | 193 | 118 | 146 | N/A |
| 6/30/2022 | 2,720 | 177 | 21 | 42 | N/A |
| 3/31/2022 | 2,726 | 176 | 80 | 103 | N/A |
| 12/31/2021 | 2,731 | 175 | 138 | 163 | N/A |
| 9/30/2021 | 2,682 | 187 | 266 | 293 | N/A |
| 6/30/2021 | 2,634 | 199 | 394 | 423 | N/A |
| 3/31/2021 | 2,531 | 179 | 270 | 297 | N/A |
| 12/31/2020 | 2,428 | 159 | 145 | 170 | N/A |
| 9/30/2020 | 2,415 | 87 | N/A | N/A | N/A |
| 6/30/2020 | 2,401 | 15 | 60 | 92 | N/A |
| 3/31/2020 | 2,367 | 145 | 185 | 216 | N/A |
| 12/31/2019 | 2,333 | 275 | 310 | 341 | N/A |
| 9/30/2019 | 1,757 | 321 | N/A | N/A | N/A |
| 6/30/2019 | 1,156 | 366 | 8 | 28 | N/A |
| 3/31/2019 | 785 | 235 | -3 | 15 | N/A |
| 12/31/2018 | 414 | 103 | -14 | 2 | N/A |
| 9/30/2018 | 387 | 114 | 7 | 25 | N/A |
| 12/31/2017 | 338 | 111 | N/A | 20 | N/A |
| 12/31/2016 | 290 | 56 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 1931's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if 1931's earnings are forecast to grow faster than the Hong Kong market
High Growth Earnings: Insufficient data to determine if 1931's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 1931's revenue is forecast to grow faster than the Hong Kong market.
High Growth Revenue: Insufficient data to determine if 1931's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 1931's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:03 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
IVD Medical Holding Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yue-Kwong Lui | Jefferies LLC |